INECO Neurociencias Oroño - Rosario

INECO Neurociencias Oroño - Rosario
Bv. Oroño 1508, Rosario, Santa Fe
Select an option

Our team

Medical staff
Marisa Vico
Yamila Margaria
Dr. Oviedo
Maria Cecilia Bahit
Keila Schwindt
Alvaro Gallegos
Maria de los Milagros Arce
Micaela Ruarte
Florencia Garavelli
Juana Torres
Cappiello Florencia

Open studies

Arterial hypertension
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening) - ls (ATTAIN-HYPERTENSION - Eli Lilly and CompanySee more
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 - ATTAIN-HYPERTENSION - Eli Lilly and CompanySee more
Obesity
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening) - ls (ATTAIN-HYPERTENSION - Eli Lilly and CompanySee more
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 - ATTAIN-HYPERTENSION - Eli Lilly and CompanySee more
Multiple Sclerosis
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) - PORTAMENTO - Hoffmann-La RocheSee more
Migraine
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine - PROSPECT-1 - H. Lundbeck A/SSee more
Myasthenia gravis
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) - MyClad - Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanySee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy